Clover Health Investments, Corp.
CLOV· Nasdaq
Released Feb 28, 2023, before the open
10-K filed Mar 1, 2023, 60 days after period end · 0001801170-23-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | — | $432.04M | $166.23M | — |
| Net Income | -$84.23M | -$187.20M |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
| -$126.39M |
| -$17.63K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.